瑞思邁通過研發、生產和分銷用於治療、診斷和管理睡眠呼吸障礙、慢性阻塞性肺病 (COPD) 及其它慢性病的醫療設備，來改善病人的生活質量。該公司致力於開發創新的產品和解決方案，用以改善受這類疾病困擾的病人的健康水準和生活質量，並喚起對未治療的睡眠呼吸障礙潛在嚴重健康後果的關注。有關瑞思邁的更多信息，請瀏覽：http:\/\/www.resmed.com\/<\/a> 。<\/p> \n

\n \n \n \n \n \n \n \n

聯繫方式：<\/b><\/span><\/p>
新聞傳媒<\/b><\/span><\/p> <\/td> \n

投資者<\/b><\/span><\/p> <\/td> \n <\/tr> \n

Gretchen Griswold <\/span><\/p> <\/td> \n

Agnes Lee<\/span><\/p> <\/td> \n <\/tr> \n

全球企業傳訊部總監<\/span><\/p> <\/td> \n

投資關係部高級總監<\/span><\/p> <\/td> \n <\/tr> \n

電話：+1-858-836-6789 <\/span><\/p> <\/td> \n

電話：+1-858-836-5971<\/span><\/p> <\/td> \n <\/tr> \n

電郵：news@resmed.com<\/a><\/span><\/p> <\/td> \n

電郵：investorrelations@resmed.com<\/a><\/span><\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div>"]; $("#dvExtra").html(content_array[0]);})();

聯繫方式：<\/b><\/span><\/p> 新聞傳媒<\/b><\/span><\/p> <\/td> \n	投資者<\/b><\/span><\/p> <\/td> \n <\/tr> \n
Gretchen Griswold <\/span><\/p> <\/td> \n	Agnes Lee<\/span><\/p> <\/td> \n <\/tr> \n
全球企業傳訊部總監<\/span><\/p> <\/td> \n	投資關係部高級總監<\/span><\/p> <\/td> \n <\/tr> \n
電話：+1-858-836-6789 <\/span><\/p> <\/td> \n	電話：+1-858-836-5971<\/span><\/p> <\/td> \n <\/tr> \n
電郵：news@resmed.com<\/a><\/span><\/p> <\/td> \n	電郵：investorrelations@resmed.com<\/a><\/span><\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div>"]; $("#dvExtra").html(content_array[0]);})();